Conventional Versus New Treatment: Comparing the Effects of Acetylcholinesterase Inhibitors and N-Methyl-D-Aspartate Receptor Antagonist With Aducanumab

Alzheimer’s dementia (AD) is the most common major neurocognitive impairment and the fifth leading cause of death in older adults in the United States. The diagnosis is clinical; however, laboratory tests and imaging frequently rule out secondary causes of dementia. Unfortunately, the treatment avai...

Descripción completa

Detalles Bibliográficos
Autores principales: Chin, Elysia, Jaqua, Ecler, Safaeipour, Mary, Ladue, Tyler
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719396/
https://www.ncbi.nlm.nih.gov/pubmed/36475205
http://dx.doi.org/10.7759/cureus.31065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719396/
https://www.ncbi.nlm.nih.gov/pubmed/36475205
http://dx.doi.org/10.7759/cureus.31065

Ejemplares similares